Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 5 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Verve Therapeutics Inc have a median target of 24.50, with a high estimate of 40.00 and a low estimate of 15.00. The median estimate represents a 355.39% increase from the last price of 5.38.
High | 643.5% | 40.00 |
Med | 355.4% | 24.50 |
Low | 178.8% | 15.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | +8.98% |
Average growth rate | +13.91% |
More ▼
Revenue history & estimates in USD
Average growth rate | +35.54% |
Average growth rate | +505.77% |
More ▼